Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
Amphastar Pharmaceuticals IncAMPH8.511.861.856.8023.85%7.91%0.00$31.43$41.5427,242$27.62

Detail of Amphastar Pharmaceuticals Inc

 
CEO
Dr. Yongfeng Zhang Ph.D.
Employees
1761
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Market cap
$1B

Company details

Amphastar Pharmaceuticals Inc. is a specialty pharmaceutical company dedicated to the development, manufacture, and marketing of innovative generic and proprietary injectable, inhalation, and intranasal products. Amphastar's primary function is to provide cost-effective medications that improve patient care and accessibility to treatment. The company’s product portfolio includes critical drugs used in hospitals and other medical settings, targeting areas like endocrinology, anesthesia, and pain management. Amphastar Pharmaceuticals impacts the healthcare industry significantly by supplying generic alternatives to high-cost brand-name drugs, greatly aiding healthcare systems in managing medication expenditures. Headquartered in Rancho Cucamonga, California, Amphastar operates both in the United States and internationally, emphasizing rigorous quality control and regulatory compliance in its production processes. The company plays a vital role in the healthcare market by ensuring a steady supply of essential medicines, helping to alleviate shortages and support the delivery of efficient medical care.

Revenue
Cost of goods
Gross profit
OE
R&D
G&A
OI
OIE
PI
TAX
NI
Revenue (Rev)
$723.55M
Cost of goods (CoG)
-$340.20M
Gross profit (GP)
$383.35M
Operating expense (OE)
-$169.09M
Research and development (R&D)
-$76.19M
General and administrative (G&A)
-$92.90M
Operating income (OI)
$214.26M
Other income expense (OIE)
-$4.36M
Pretax income (PI)
$187.15M
Tax (TAX)
-$28.35M
Net income (NI)
$157.72M
Amphastar Pharmaceuticals Inc
AMPH • XNGS • US
$27.62
-15.27 (-35.60%)
Stock vs Industry average
  • Industry average

Trailing annual dividend rate
$0.00
Payout ratio
0.00%
EPS
$3.24
Margin profit
21.80%
52 week low
$26.99
52 week high
$53.400002
50-day simple moving average
$30.43
200-day simple moving average
$31.43
Percent held by insiders
22.48%
Percent held by institutions
75.40%
Dividend yield
0.00%

Change of shares

Cash vs Debt

Insider Trading

Comparison of selected companies

 
%
Price change
AMPH -35.60%
eps change
AMPH -17.82%